Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.10.2010 | Series C | $30M | - |
Mentions in press and media 3
| Date | Title | Description |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appetite for R&D risk | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. But from 2013 through 2015 generalist investors got over their fears and jumped into one of the hottest stock games on the planet. Fund... |
| 12.10.2010 | Synosia Therapeutics Raises $30M in Series C Financing | Synosia Therapeutics, a Basel, Switzerland-based biotherapeutics company focused on neurology and psychiatry, has raised $30m in a Series C financing round. The round was led by new investor UCB, which committed $20m, with participation fro... |
| 12.10.2010 | SYNOSIA THERAPEUTICS RAISES $30M IN SERIES C FINANCING | - |